WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Lazard Capital Markets 5th Annual Healthcare Conference on Tuesday, November 18, 2008 in New York City. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company; highlight details on the recent market performance of ANTARA® (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets; and discuss the Company’s recently announced results for the third quarter of 2008, in which Oscient recorded $21.8 million in revenues.
